Editorial
doi: 10.1056/NEJMe020172.
Reducing cardiovascular risk in type 2 diabetes
- PMID: 12556548
- DOI: 10.1056/NEJMe020172
Item in Clipboard
Editorial
Reducing cardiovascular risk in type 2 diabetes
N Engl J Med.
.
No abstract available
Comment in
-
Multifactorial intervention and cardiovascular disease in type 2 diabetes.N Engl J Med. 2003 May 8;348(19):1925-7; author reply 1925-7. N Engl J Med. 2003. PMID: 12739536 No abstract available.
Comment on
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.N Engl J Med. 2003 Jan 30;348(5):383-93. doi: 10.1056/NEJMoa021778. N Engl J Med. 2003. PMID: 12556541 Clinical Trial.
Similar articles
-
Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications.Dan Med Bull. 2006 Aug;53(3):258-84. Dan Med Bull. 2006. PMID: 17092449 Review. No abstract available.
-
Reduction of body iron stores and the prevention of type 2 diabetes.Am J Med. 2007 Jan;120(1):e13; author reply e15. doi: 10.1016/j.amjmed.2005.11.024. Am J Med. 2007. PMID: 17208061 No abstract available.
-
Effect of a multifactorial intervention on mortality in type 2 diabetes.N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245. N Engl J Med. 2008. PMID: 18256393 Clinical Trial.
-
Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.Arch Intern Med. 2003 May 12;163(9):1025-9. doi: 10.1001/archinte.163.9.1025. Arch Intern Med. 2003. PMID: 12742799 Review.
-
Reducing diabetes incidence through the inhibition of the renin-angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?J Cardiovasc Med (Hagerstown). 2007 Jul;8(7):473-82. doi: 10.2459/01.JCM.0000278445.04613.27. J Cardiovasc Med (Hagerstown). 2007. PMID: 17568278 Review.
Cited by
-
Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes.Anesthesiology. 2012 Oct;117(4):735-44. doi: 10.1097/ALN.0b013e3182655e96. Anesthesiology. 2012. PMID: 22820846 Free PMC article.
-
A study on the glycemic, lipid and blood pressure control among the type 2 diabetes patients of north Kerala, India.Indian Heart J. 2018 Jul-Aug;70(4):482-485. doi: 10.1016/j.ihj.2017.10.007. Epub 2017 Oct 12. Indian Heart J. 2018. PMID: 30170640 Free PMC article.
-
Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control.Diabetes Care. 2011 Sep;34(9):1934-42. doi: 10.2337/dc11-0366. Epub 2011 Jul 25. Diabetes Care. 2011. PMID: 21788632 Free PMC article. Clinical Trial.
-
Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial.Int J Environ Res Public Health. 2021 May 16;18(10):5300. doi: 10.3390/ijerph18105300. Int J Environ Res Public Health. 2021. PMID: 34065775 Free PMC article. Clinical Trial.
-
Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress.Cardiovasc Diabetol. 2003 Feb 12;2:2. doi: 10.1186/1475-2840-2-2. Cardiovasc Diabetol. 2003. PMID: 12628022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
